ShotBlocker During Intramuscular Injection Randomized Control Trial
Sponsor: Lauren Fortier • ClinicalTrials.gov ID: NCT06624176
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The objective of this trial is to evaluate the effect of Bionix ShotBlocker on pain of injection of the first Hepatitis B vaccine in healthy newborns. ShotBlocker is a pain reducing tool used in babies, children, and adults for injections. Swaddling during the injection and administration of oral sucrose prior to the injection are established standards of care for painful procedures in neonates. The investigators hypothesize that the use of ShotBlocker in addition to swaddling and oral sucrose administration will lessen the pain response.
Interventions
-
Bionix ShotBlocker
(Device)
This is a hospital-approved device used as standard-of-care in older children and adults to reduce pain during painful procedures. It is not considered established standard-of-care in the infant cohort.
-
Swaddling
(Other)
Standard of care swaddling
-
Sucrose administration
(Other)
Standard of care sucrose administration
-
Masimo Rad-97 Oximeter probe
(Other)
Oximeter probe
Eligibility criteria
Conditions
Locations
- UMass Memorial Medical Center- Memorial Campus — Worcester, Massachusetts, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record